Delisting riskPopularity #4,283
LUCY · NASDAQ · Medical - Instruments & Supplies

Innovative Eyewear (LUCY)

Camera-free smart eyewear for everyday, sport, and safety use.

$0.9200
vs last close−0.03 (−3.15%)
Loading prices…

Innovative Eyewear, Inc.LUCY
Health Care

Designs camera-free smart glasses that combine open-ear audio, calls, phone voice assistants, and AI access with optical, sport, and safety eyewear. Revenue is centered on direct e-commerce, with outsourced China-based production and North America as the primary market.

Designs and sells camera-free, open-ear Bluetooth smart eyewear across the Lucyd Lyte, Lucyd Armor, Nautica Powered by Lucyd, Eddie Bauer Powered by Lucyd, and Reebok Powered by Lucyd lines. Frames add speakers, microphones, touch controls, and phone-based voice and AI access to prescription, lifestyle, sport, and safety eyewear. Revenue comes mainly from direct e-commerce and wholesale optical and retail partners, primarily in North America.

Uses familiar eyeglass form factors rather than display-heavy AR/VR headsets and iterates products with customer and retail-partner feedback. Product design is Miami-based, production is contracted in China, and a third-party Miami laboratory fits prescription lenses. Brand licenses, marketplace access, outside AI and smartphone platforms, limited suppliers, FDA oversight, and safety certifications shape operations. Safety-line positioning depends on maintaining applicable U.S., Canadian, and European certifications.

Company facts

CEOHarrison R. Gross
ListedAug 15, 2022
ExchangeNASDAQ
HeadquartersNorth Miami, FL
CountryUnited States
Employees13
CIK0001808377
ISINUS45791D2080

Market cap$6.0M
EPS (ttm)−$1.35
P/E (ttm)−0.7036
ROE-88.9%
P/B0.8675
P/S1.75
Dividend yieldDiv yield
Beta1.95vs XLV 0.61

No analyst consensus on record.

Next report
Nov 12, 26
in 51 days
EPS estimate
−$0.35
Revenue estimate
$2.0M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.41−$0.72−$0.66−$0.38−$0.28−$0.37−$0.26Pending
Estimate−$1.22−$0.73−$0.77−$0.49−$0.43−$0.47−$0.37−$0.35
Surprise+66.4%+1.4%+14.3%+22.4%+34.9%+21.3%+29.7%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$690.7K$454.5K$579.2K$668.1K$959.8K$773.6K$1.0MPending
Estimate$700.0K$1.0M$1.0M$1.0M$1.2M$700.0K$900.0K$2.0M
Surprise−1.3%−54.5%−42.1%−33.2%−20.0%+10.5%+12.3%
Estimate−$0.35
ReportedDue Nov 12, 2026
Estimate$2.0M
ReportedDue Nov 12, 2026
View details

Debt to equity0.70%
Current ratio1,205.90%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$253.6K$690.7K$454.5K$579.2K$668.1K$959.8K$773.6K$1.0M
Net income−$1.7M−$2.1M−$1.8M−$2.1M−$1.8M−$1.9M−$2.3M−$1.7M
Net margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income−$1.8M−$2.2M−$1.9M−$2.2M−$1.9M−$2.5M−$2.4M−$1.7M
YoY growthLoss widenedLoss narrowedLoss narrowedLoss widenedLoss widenedLoss widenedLoss widenedLoss narrowed

Balance sheet, Jun 30, 2026Cash & short-term investments $3.7M · Total debt $49.4K · Total assets $7.5M · Shareholders' equity $6.9M

Revenue
$1.0M
Operating income
−$1.7M
Net income
−$1.7M
View details

No dividends on record.

Unavailable right now.

Unavailable right now.